Zoladex Related Clinical Trials
Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-Menopausal Patients [Active, not recruiting]
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-Menopausal Women [Suspended]
Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer [Recruiting]
A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer [Recruiting]
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women [Recruiting]
MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer [Not yet recruiting]
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Recruiting]
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin [Not yet recruiting]
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients [Recruiting]
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer [Recruiting]
Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locally Advanced Prostate Cancer [Recruiting]
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women [Active, not recruiting]
Ipilimumab + Androgen Deprivation Therapy in Prostate Cancer [Recruiting]
Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer [Recruiting]
Casodex/Zoladex Biomarkers in Localised Prostate Cancer [Completed]
Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) [Active, not recruiting]
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Recruiting]
Zoladex Plus Tamoxifen in Breast Cancer [Recruiting]
Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy [Recruiting]
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy [Recruiting]
Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis [Recruiting]
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer [Recruiting]
Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone [Recruiting]
Pregnancy Outcome After IVF/ICSI in Endometriosis Patients Stage I and II [Recruiting]
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer [Completed]
Leuprolide or Goserelin Plus Thalidomide Compared With Leuprolide or Goserelin Alone in Treating Patients With Nonmetastatic Prostate Cancer [Active, not recruiting]
Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer [Completed]
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-Positive Patients [Completed]
Study on Pre-Menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex [Completed]
Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial [Completed]
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Recruiting]
Non-Interventional Study of Zoladex in Endometriosis [Recruiting]
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer [Active, not recruiting]
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Active, not recruiting]
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer [Recruiting]
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer [Recruiting]
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer [Recruiting]
A Trial of Degarelix in Patients With Prostate Cancer [Recruiting]
Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis [Completed]
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer [Completed]
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0 Prostate Cancer [Recruiting]
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer [Active, not recruiting]
Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS [Recruiting]
Leuprolide Acetate or Goserelin With or Without GDC-0449 Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer [Recruiting]
Dose-Response of Gonadal Steroids and Bone Turnover in Men [Recruiting]
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Active, not recruiting]
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Active, not recruiting]
One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population [Recruiting]
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer [Recruiting]
Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment [Recruiting]
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer [Active, not recruiting]
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer [Recruiting]
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer [Recruiting]
Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients [Recruiting]
Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer [Completed]
Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy [Recruiting]
CMAB vs IMAB in Metastatic Prostate Cancer [Withdrawn]
Neo-adjuvant Abiraterone + LHRH Versus LHRH in Prostate Cancer [Recruiting]
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle [Active, not recruiting]
Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer [Recruiting]
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer [Recruiting]
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer [Active, not recruiting]
Goserelin Plus Letrozole in Premenopausal Patients Versus Letrozole Alone in Postmenopausal Patients With Metastatic Breast Cancer [Recruiting]
Insulin Sensitivity in Men With the Metabolic Syndrome [Recruiting]
Pazopanib After Leuprolide or Goserelin in Treating Patients With Relapsed Prostate Cancer [Recruiting]
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy [Recruiting]
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer [Completed]
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Active, not recruiting]
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Intensity-Modulated Radiation Therapy, Docetaxel, and Hormone Therapy in Treating Patients With High-Risk Locally Advanced Prostate Cancer With Pelvic Lymph Node Metastasis
Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy [Active, not recruiting]
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases [Active, not recruiting]
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer [Active, not recruiting]
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer [Completed]
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment [Active, not recruiting]
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer [Active, not recruiting]
Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer [Recruiting]
Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS) [Recruiting]
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer [Not yet recruiting]
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer [Recruiting]
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer [Recruiting]
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer [Recruiting]
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer [Recruiting]
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Recruiting]
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Recruiting]
Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer [Recruiting]
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [No longer recruiting]
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [No longer recruiting]
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer [Completed]
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer [Completed]
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer [Active, not recruiting]
Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer [No longer recruiting]
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome [Recruiting]
Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts [Recruiting]
Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids [Recruiting]
Phase II Trial: Higher Dose Casodex in Hormone Refractory Prostate Cancer Patients. [Recruiting]
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Recruiting]
|
